Glimepiride
Links shared publicly online about this topic
ingentaconnect Efficacy and safety of treatment with sitagliptin or glimepiride ...
ingentaconnect.com — “ingentaconnect Efficacy and safety of treatment with sitagliptin or glimepiride ...” View full resource at ingentaconnect.com
Most Recently Shared on January 13, 2011 at 10:18 pm By:
Yvo Sijpkens MD Internist, Nephrologist, Physician, and Doctor
In patients with type 2 #diabetes sitagliptin or glimepiride led to similar improvement in glycaemic control http://bit.ly/hGFXCG
Sitagliptin Rivals Glimepiride For Glycemic Control With Less Hypoglycemia And No Weight Gain
medicalnewstoday.com — “The addition of the highly selective, once-daily dipeptidyl peptidase (DPP)-4 inhibitor sitagliptin (Januvia), compared with glimepiride (Amaryl), to background metformin therapy provides similar” View full resource at medicalnewstoday.com
Most Recently Shared on September 20, 2010 at 3:08 pm By:
Sitagliptin Rivals Glimepiride For Glycemic Control With Less Hypoglycemia And No Weight Gain http://mnt.to/3K3V #healthnews
New Data For Linagliptin Show Clinically Meaningful Efficacy Similar To Glimepiride But With Fewer Cardiovascular Events
medicalnewstoday.com — “Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) today announced Phase III study results for linagliptin (proposed trade name Trajenta® in Europe), demonstrating improved glycaemic c” View full resource at medicalnewstoday.com
Most Recently Shared on June 27, 2011 at 2:05 pm By:
New Data For Linagliptin Show Clinically Meaningful Efficacy Similar To Glimepiride But With Fewer Cardiovascular Events http://mnt.to/3XGQ
Journal of the Brazilian Chemical Society - Development and validation of an UV-derivative spectrophotometric method for determination of glimepiride in tablets
scielo.br — “Journal of the Brazilian Chemical Society - Development and validation of an UV-derivative spectrophotometric method for determination of glimepiride in tablets” View full resource at scielo.br
Most Recently Shared on February 20, 2011 at 1:32 am By:
Development and validation of an UV-derivative spectrophotometric method for determination of glimepiride in tab... http://bit.ly/fsJmkw
Glitazone-like action of glimepiride and glibenclamide in primary human adipocytes - Mayer - Diabetes, Obesity and Metabolism - Wiley Online Library
onlinelibrary.wiley.com — “Glitazone-like action of glimepiride and glibenclamide in primary human adipocytes - Mayer - Diabetes, Obesity and Metabolism - Wiley Online Library” View full resource at onlinelibrary.wiley.com
Most Recently Shared on April 8, 2011 at 10:11 pm By:
Endocrinology Wisdom OW Health
Glitazoneâ€*like action of glimepiride and glibenclamide in primary human adipocytes: Conclusions: In primary hu... http://bit.ly/gcHlna
Family Med Medical News about Diabetes Mellitus, Type 2; liraglutide glimepiride
mdlinx.com — “Patient-reported outcomes in patients with type 2 diabetes treated with liraglutide or glimepiride, both as add-on to metformin” View full resource at mdlinx.com
Most Recently Shared on June 23, 2010 at 4:40 am By:
Sandeep Pulim MD Physician, Doctor, and Health Communicator
Patient-reported outcomes in patients with type 2 diabetes treated with liraglutide or glimepiride, bot... http://bit.ly/dwUBxT #GM #mdlinx
MedWire News - Diabetes - Glycemic control better if glimepiride continued when switching to insulin
medwire-news.md — “MedWire News Patients with Type 2 diabetes achieve better glycemic control when starting insulin therapy if they continue glimepiride treatment, Japanese researchers report. MedWire News” View full resource at medwire-news.md
Most Recently Shared on September 3, 2009 at 5:50 pm By:
RT @MedWireNews: Glycemic control better if glimepiride continued when switching to insulin http://tinyurl.com/l7rlb4 #diabetes #insulin
Dapagliflozin added to glimepiride therapy reduces HbA1c in adult type 2 diabetes patients
news-medical.net — “Bristol-Myers Squibb Company and AstraZeneca today announced results from a randomized, double blind Phase 3 clinical study, which demonstrated that the addition of the investigational drug dapagliflozin to existing glimepiride (sulphonylurea) therapy produced significant reductions in glycosylated hemoglobin levels (HbA1c) in adult patients with type 2 diabetes compared to glimepiride alone.” View full resource at news-medical.net
Most Recently Shared on September 20, 2010 at 1:46 pm By:
Obesity News: Dapagliflozin added to glimepiride therapy reduces HbA1c in adult type 2 diabetes patients: Bristo... http://twurl.nl/oogne4
Sitagliptin Rivals Glimepiride For Glycemic Control With Less Hypoglycemia And No Weight Gain | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.com
keyvive.com — “Sitagliptin Rivals Glimepiride For Glycemic Control With Less Hypoglycemia And No Weight Gain | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.com” View full resource at keyvive.com
Most Recently Shared on September 20, 2010 at 9:50 pm By:
Sitagliptin Rivals Glimepiride For Glycemic Control With Less Hypoglycemia And No Weight Gain… http://goo.gl/fb/1j6nu
24-Week Phase 3 Study Found Investigational Drug Dapagliflozin Improved Glycosylated Hemoglobin (HbA1c) When Added to Glimepiride in Adults with Type 2 Diabetes Mellitus - Drugs.com MedNews
drugs.com — “Sep 20, 2010 - Bristol-Myers Squibb Company (NYSE BMY) and AstraZeneca (NYSE AZN) today announced results from a randomized, double blind Phase 3 clinical study” View full resource at drugs.com
Most Recently Shared on September 20, 2010 at 12:10 pm By:
Drugs and Devices OW OW Health
24-Week Phase 3 Study Found Investigational Drug Dapagliflozin Improved Glycosylated Hemoglobin (HbA1c) When ... http://bit.ly/dxbKJr #drug
Liraglutide provides similar glycaemic control as glimepiride (both in combination with metformin) and reduces body weight and systolic blood pressure in Asian population with type 2 diabetes from China, South Korea and India: a 16-week, randomized, doubl
onlinelibrary.wiley.com — “Liraglutide provides similar glycaemic control as glimepiride (both in combination with metformin) and reduces body weight and systolic blood pressure in Asian population with type 2 diabetes from China, South Korea and India: a 16-week, randomized, double-blind, active control trial* - Yang - 2010 - Diabetes, Obesity and Metabolism - Wiley Online Library” View full resource at onlinelibrary.wiley.com
Most Recently Shared on November 30, 2010 at 2:51 pm By:
Liraglutide provides similar glycaemic control as glimepiride (both in combination with metformin) and reduces b... http://bit.ly/h82Fjn
24-Week Phase 3 Study Found Investigational Drug Dapagliflozin Improved Glycosylated Hemoglobin (HbA1c) When Added To Glimepiride | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.com
keyvive.com — “24-Week Phase 3 Study Found Investigational Drug Dapagliflozin Improved Glycosylated Hemoglobin (HbA1c) When Added To Glimepiride | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.com” View full resource at keyvive.com
Most Recently Shared on September 21, 2010 at 2:22 pm By:
24-Week Phase 3 Study Found Investigational Drug Dapagliflozin Improved Glycosylated… http://goo.gl/fb/8shaz
24-Week Phase 3 Study Found Investigational Drug Dapagliflozin Improved Glycosylated Hemoglobin (HbA1c) When Added to Glimepiride in Adults with Type 2 Diabetes Mellitus - News Press Release | PharmiWeb.com
pharmiweb.com — “Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) today announced results from a randomized, double blind Phase 3 clinical study, which demonstrated that the addition of the investigational drug dapagliflozin to existing gl” View full resource at pharmiweb.com
Most Recently Shared on September 20, 2010 at 1:41 pm By:
Urology & Nephrology OW Health
Press Release: Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) today announced results from a... http://bit.ly/9IP0js
GLP-1 analog outperforms sulfonylurea in type 2 diabetes
theheart.org — “In a head-to-head comparison, liraglutide reduced A1C levels more effectively with virtually no hypoglycemia and with weight loss, compared with weight gain with glimepiride.” View full resource at theheart.org
Most Recently Shared on June 15, 2009 at 6:05 pm By:
heartwire: GLP-1 inhibitor outperforms sulfonylurea in type 2 diabetes http://bit.ly/vgZEm
What Are My Options? - American Diabetes Association
diabetes.org — “Explore the six different types of oral diabetes medications on the market today.” View full resource at diabetes.org
Most Recently Shared on July 20, 2010 at 9:29 pm By:
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Yvo Sijpkens MD
Internist-Nephrologist, Expert in Hypertension and Chronic Kidney Disease, Focus on Cardiovascular and Renal Protection by Lifestyle, Vit D and Pharmacotherapy
-
MNT Health News
Featured health news published by Medical News Today and chosen by the editorial team.
-
MNT Diabetes News
The latest diabetes news published daily. Articles from research centers, universities and prestigious journals.
Advertisement
